A clinical study to establish a database for evaluation of disease progression in adults patients with chronic kidney disease

Not Applicable

• Conditions: Health Condition 1: null- Chronic Kidney Disease

• Registration Number: CTRI/2012/06/002743
• Lead Sponsor: Fresenius Kabi Asia Pacific Ltd

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: Open to Recruitment
• Sex: Not specified
• Target Recruitment: 2500

Inclusion Criteria

1.Male and female patients with age >= 18 years and regularly attending a given site

2.Patients with CKD (glomerular filtration rate (GFR) < 90 ml/min per 1.73 m2) stages 2 and below (stage 2 to 5)

3.Patients with life expectancy of at least 6 months

4.Patients who are willing and able to adhere to the protocol requirements

Exclusion Criteria

1.Patients who have undergone kidney transplant

2.Patients who have a sustained sitting systolic blood pressure (BP) more than 160 mmHg or sustained sitting diastolic BP more than 110 mmHg

3.Patients with an independently co-existing life-threatening disease, such as cancer

4.Patients who have undergone previous carotid artery surgery and/or a carotid artery stenosis greater than 75% at baseline.

5.Patients with history of co-morbidities that in the investigatorâ??s opinion would interfere with the study participation and impact life expectancy

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Clinical course and therapy sequences of the Chronic Kidney Disease (CKD)Timepoint: Death or day of surgery for renal transplant or lost to follow-up

Secondary Outcome Measures

Name	Time	Method
Adverse events, mortality, co-morbiditiesTimepoint: Death or day of surgery for renal transplant or lost to follow-up